\-\ Texto\\:\\ \ \(0\)\
\-\ 71\\ yo\\ male\\ nad\\,\\ non\\-toxic\\ appearing\\.\ \(0\)\
\-\ liver\\ margin\\ palpable\\ 12\\ cm\\ below\\ the\\ costal\\ angle\\ at\\ the\\ mid\\-clavicular\\ line\\.\\ \\ very\\ firm\\ liver\\,\\ minimally\\ tender\\ to\\ palpation\\,\\ no\\ us\\ murphy\\'s\\ sign\ \(0\)\
\-\ numerous\\,\\ hypoechoic\\ mass\\ lesions\\ within\\ the\\ hepatic\\ parenchyma\\,\\ cholecystectomy\\,\\ normal\\ hepatic\\ and\\ portal\\ venous\\ flow\\.\ \(0\)\
\-\ ct\\ demonstrates\\ multiple\\ hypoattentuating\\ foci\\ within\\ all\\ lobes\\ of\\ the\\ liver\\,\\ without\\ significant\\ enhancement\\.\\ \\ celiac\\ and\\ portocaval\\ lymphadenopathy\\.\ \(0\)\
\-\ metastatic\\ intrahepatic\\ cholangiocarcinoma\ \(0\)\
\-\ metastatic\\ disease\\ of\\ the\\ colon\\,\\ other\\ gi\\ sites\\ \\(pancreatic\\,\\ gastric\\,\\ salivary\\ duct\\)\\,\\ melanoma\\,\\ hepatocellular\\,\\ cholangiocarcinoma\\.\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ septic\\ emboli\\/multifocal\\ abscesses\\ \\(candida\\)\ \(0\)\
\-\ 71\\ yo\\ male\\ with\\ pmh\\ of\\ htn\\,\\ cad\\,\\ cholelithiasis\\ with\\ cholecystectomy\\.\\ \\ admitted\\ because\\ of\\ retrosternal\\ chest\\ pain\\,\\ cardiac\\ enzymes\\ negative\\.\\ \\ echo\\ cardiogram\\ revealed\\ normal\\ cardiac\\ structures\\ and\\ function\\,\\ incidentally\\ noted\\ heterogeneous\\ hepatic\\ parenchyma\\.\\ \\ he\\ was\\ referred\\ to\\ us\\ for\\ a\\ dedicated\\ ruq\\ study\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hepatic\\:\\ 0\\.23659023935072165\ \(0\)\
\-\ cholangiocarcinoma\\:\\ 0\\.22047717616608697\ \(0\)\
\-\ liver\\:\\ 0\\.20494881137971094\ \(0\)\
\-\ 71\\:\\ 0\\.1923207117365979\ \(0\)\
\-\ cholecystectomy\\:\\ 0\\.1923207117365979\ \(0\)\
\-\ parenchyma\\:\\ 0\\.16089395484851127\ \(0\)\
\-\ hypoattentuating\\:\\ 0\\.15837238194979067\ \(0\)\
\-\ cardiogram\\:\\ 0\\.15837238194979067\ \(0\)\
\-\ us\\:\\ 0\\.15754922383708891\ \(0\)\
\-\ portocaval\\:\\ 0\\.1513332658424184\ \(0\)\
\-\ cardiac\\:\\ 0\\.14707678546406133\ \(0\)\
\-\ candida\\:\\ 0\\.12587677976414563\ \(0\)\
\-\ costal\\:\\ 0\\.12459022116751098\ \(0\)\
\-\ cad\\:\\ 0\\.12459022116751098\ \(0\)\
\-\ retrosternal\\:\\ 0\\.12459022116751098\ \(0\)\
\-\ yo\\:\\ 0\\.12373810039235375\ \(0\)\
\-\ dedicated\\:\\ 0\\.12121955695679433\ \(0\)\
\-\ salivary\\:\\ 0\\.11674348984289187\ \(0\)\
\-\ enzymes\\:\\ 0\\.11318813669430028\ \(0\)\
\-\ metastatic\\:\\ 0\\.10862727321445777\ \(0\)\
\-\ murphy\\:\\ 0\\.10819380433498575\ \(0\)\
\-\ celiac\\:\\ 0\\.10771814180157342\ \(0\)\
\-\ intrahepatic\\:\\ 0\\.1039383322657137\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.10180988283077202\ \(0\)\
\-\ abscesses\\:\\ 0\\.10052332423413737\ \(0\)\
\-\ ruq\\:\\ 0\\.10052332423413737\ \(0\)\
\-\ cholelithiasis\\:\\ 0\\.09932556683586548\ \(0\)\
\-\ the\\:\\ 0\\.09880152263617199\ \(0\)\
\-\ htn\\:\\ 0\\.09875631595490035\ \(0\)\
\-\ nad\\:\\ 0\\.09847854048607962\ \(0\)\
\-\ sites\\:\\ 0\\.09664941909433164\ \(0\)\
\-\ portal\\:\\ 0\\.09477076672339976\ \(0\)\
\-\ septic\\:\\ 0\\.0941155721202412\ \(0\)\
\-\ minimally\\:\\ 0\\.09390255599462442\ \(0\)\
\-\ melanoma\\:\\ 0\\.09248042589094244\ \(0\)\
\-\ echo\\:\\ 0\\.09171719984752807\ \(0\)\
\-\ within\\:\\ 0\\.09122139588509015\ \(0\)\
\-\ firm\\:\\ 0\\.08977643436408522\ \(0\)\
\-\ pancreatic\\:\\ 0\\.08977643436408522\ \(0\)\
\-\ pmh\\:\\ 0\\.08961030298695936\ \(0\)\
\-\ male\\:\\ 0\\.08818496284786365\ \(0\)\
\-\ margin\\:\\ 0\\.08686343988725215\ \(0\)\
\-\ angle\\:\\ 0\\.08686343988725215\ \(0\)\
\-\ duct\\:\\ 0\\.08524733462112094\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.08461597062764484\ \(0\)\
\-\ incidentally\\:\\ 0\\.08436971690407552\ \(0\)\
\-\ numerous\\:\\ 0\\.08365124486819982\ \(0\)\
\-\ gastric\\:\\ 0\\.08341821322937294\ \(0\)\
\-\ gi\\:\\ 0\\.0831882681931727\ \(0\)\
\-\ lobes\\:\\ 0\\.08262638755066583\ \(0\)\
\-\ below\\:\\ 0\\.08155440531973687\ \(0\)\
\-\ admitted\\:\\ 0\\.08114348444511496\ \(0\)\
\-\ foci\\:\\ 0\\.08094161477023595\ \(0\)\
\-\ normal\\:\\ 0\\.08086751615388778\ \(0\)\
\-\ function\\:\\ 0\\.0801568214261688\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.08006117051517911\ \(0\)\
\-\ appearing\\:\\ 0\\.0791325750422976\ \(0\)\
\-\ of\\:\\ 0\\.07751983772006943\ \(0\)\
\-\ line\\:\\ 0\\.07716835105099157\ \(0\)\
\-\ colon\\:\\ 0\\.07540394770782781\ \(0\)\
\-\ structures\\:\\ 0\\.07441164355270603\ \(0\)\
\-\ referred\\:\\ 0\\.07327830402585027\ \(0\)\
\-\ tender\\:\\ 0\\.07239750517258416\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.07167654636088915\ \(0\)\
\-\ very\\:\\ 0\\.07104097934198937\ \(0\)\
\-\ venous\\:\\ 0\\.07070386979002616\ \(0\)\
\-\ palpable\\:\\ 0\\.06957301265345528\ \(0\)\
\-\ because\\:\\ 0\\.06921185795024139\ \(0\)\
\-\ sign\\:\\ 0\\.06856044602417105\ \(0\)\
\-\ 12\\:\\ 0\\.06769703402293029\ \(0\)\
\-\ palpation\\:\\ 0\\.06678550727271731\ \(0\)\
\-\ study\\:\\ 0\\.06604664698267486\ \(0\)\
\-\ flow\\:\\ 0\\.06596175392144508\ \(0\)\
\-\ revealed\\:\\ 0\\.06493419981222759\ \(0\)\
\-\ and\\:\\ 0\\.0613907295504354\ \(0\)\
\-\ negative\\:\\ 0\\.06130951334871764\ \(0\)\
\-\ lymphoma\\:\\ 0\\.05897918703810424\ \(0\)\
\-\ all\\:\\ 0\\.058950889401149995\ \(0\)\
\-\ he\\:\\ 0\\.05864262212376017\ \(0\)\
\-\ significant\\:\\ 0\\.05717840948355459\ \(0\)\
\-\ enhancement\\:\\ 0\\.0570006110384979\ \(0\)\
\-\ cm\\:\\ 0\\.05687471783686234\ \(0\)\
\-\ lesions\\:\\ 0\\.05687471783686234\ \(0\)\
\-\ noted\\:\\ 0\\.05250617535107631\ \(0\)\
\-\ chest\\:\\ 0\\.0522736638877256\ \(0\)\
\-\ without\\:\\ 0\\.05223521293861248\ \(0\)\
\-\ other\\:\\ 0\\.051428470661475344\ \(0\)\
\-\ demonstrates\\:\\ 0\\.049752177270888764\ \(0\)\
\-\ to\\:\\ 0\\.049515190309340394\ \(0\)\
\-\ multiple\\:\\ 0\\.04843829504882135\ \(0\)\
\-\ disease\\:\\ 0\\.04156976232435076\ \(0\)\
\-\ with\\:\\ 0\\.03878307790231761\ \(0\)\
\-\ mass\\:\\ 0\\.03782725897423233\ \(0\)\
\-\ ct\\:\\ 0\\.03770209191128745\ \(0\)\
\-\ at\\:\\ 0\\.03740532235257674\ \(0\)\
\-\ pain\\:\\ 0\\.03543699306906829\ \(0\)\
\-\ was\\:\\ 0\\.03451333927064664\ \(0\)\
\-\ no\\:\\ 0\\.03220380596934922\ \(0\)\
\-\ for\\:\\ 0\\.03001558417757793\ \(0\)\
